Literature DB >> 17018381

Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease.

Subha V Raman1, Orlando P Simonetti, Spero R Cataland, Eric H Kraut.   

Abstract

BACKGROUND AND OBJECTIVES: Patients with sickle cell disease (SCD) have multi-organ manifestations of microvascular disease, though cardiac manifestations have been poorly characterized in vivo. This study sought to characterize myocardial characteristics in adult patients with SCD. DESIGN AND METHODS: Twenty-two consecutive outpatients and 11 age-matched controls underwent magnetic resonance imaging to assess myocardial perfusion reserve as well as left and right ventricular size and function and myocardial iron. Computed tomography of the coronary arteries was performed to assess epicardial coronary stenosis.
RESULTS: Three of 22 outpatients with clinically stable SCD and no controls had abnormal myocardial perfusion reserve limited to the subendocardium, consistent with microvascular disease. Coronary arteries were free of disease as detectable by computed tomography angiography. Myocardial T2* was normal in all subjects (29 +/- 5 ms, median 29 ms), consistent with absence of cardiac iron deposition despite a high prevalence of hepatic iron overload (liver T2* 14 +/- 9 ms, median 12.0 ms). SCD patients had right ventricular enlargement and dysfunction (right ventricular ejection fraction 45 +/- 15 in SCD patients vs. 58 +/- 5% in controls, p=0.001) even in the absence of overt pulmonary hypertension. INTERPRETATION AND
CONCLUSIONS: A subset of adult SCD patients may have myocardial ischemia in the absence of infarcted myocardium, myocardial iron overload, or coronary artery disease. Right ventricular dysfunction is present in stable SCD patients, despite normal resting pulmonary artery pressures. These findings could represent under-recognized mechanisms for chest pain and mortality in this population, and warrant further investigation in SCD crises.

Entities:  

Mesh:

Year:  2006        PMID: 17018381

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  14 in total

1.  Remodeling of the ischemia-reperfused murine heart: 11.7-T cardiac magnetic resonance imaging of contrast-enhanced infarct patches and transmurality.

Authors:  Surya C Gnyawali; Sashwati Roy; Molly McCoy; Sabyasachi Biswas; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

2.  Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease.

Authors:  Courtney D Fitzhugh; Naudia Lauder; Jude C Jonassaint; Marilyn J Telen; Xiongce Zhao; Elizabeth C Wright; Francis R Gilliam; Laura M De Castro
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

3.  Mechanistic insights and characterization of sickle cell disease-associated cardiomyopathy.

Authors:  Ankit A Desai; Amit R Patel; Joe G N Garcia; Roberto M Lang; Homaa Ahmad; John V Groth; Thejasvi Thiruvoipati; Kristen Turner; Chattanong Yodwut; Peter Czobor; Nicole Artz; Roberto F Machado
Journal:  Circ Cardiovasc Imaging       Date:  2014-03-27       Impact factor: 7.792

Review 4.  Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease.

Authors:  Omar Niss; Charles T Quinn; Adam Lane; Joshua Daily; Philip R Khoury; Nihal Bakeer; Thomas R Kimball; Jeffrey A Towbin; Punam Malik; Michael D Taylor
Journal:  JACC Cardiovasc Imaging       Date:  2016-02-17

5.  Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome.

Authors:  Subha V Raman; Kavita Phatak; J Chad Hoyle; Michael L Pennell; Beth McCarthy; Tam Tran; Thomas W Prior; John W Olesik; Anthony Lutton; Chelsea Rankin; John T Kissel; Roula Al-Dahhak
Journal:  Eur Heart J       Date:  2010-12-14       Impact factor: 29.983

Review 6.  Imaging phenotype vs genotype in nonhypertrophic heritable cardiomyopathies: dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.

Authors:  Subha V Raman; Cristina Basso; Harikrishna Tandri; Matthew R G Taylor
Journal:  Circ Cardiovasc Imaging       Date:  2010-11       Impact factor: 7.792

Review 7.  Cardiac iron across different transfusion-dependent diseases.

Authors:  John C Wood
Journal:  Blood Rev       Date:  2008-12       Impact factor: 8.250

Review 8.  Deferasirox : a review of its use in the management of transfusional chronic iron overload.

Authors:  Lily P H Yang; Susan J Keam; Gillian M Keating
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

10.  Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside.

Authors:  Ana Villegas; Fernando A Gonzalez; Leopoldo Llorente; Santiago Redondo
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.